W.K. Kellogg Eye Center, Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor.
Center for Eye Policy and Innovation, University of Michigan, Ann Arbor.
JAMA Ophthalmol. 2020 Sep 1;138(9):974-980. doi: 10.1001/jamaophthalmol.2020.2974.
During the coronavirus disease 2019 (COVID-19) pandemic, eye care professionals caring for patients with sight-threatening diseases, such as glaucoma, have had to determine whether some patient appointments could safely get postponed, weighing the risk that the patient's glaucoma could worsen during the interim vs the morbidity risk of acquiring COVID-19 while seeking ophthalmic care. They also need to prioritize appointment rescheduling during the ramp-up phase (when pandemic-associated service reductions are eased).
To describe a flexible and scalable scoring algorithm for patients with glaucoma that considers glaucoma severity and progression risk vs the presence of high-risk features for morbidity from COVID-19, using information from a large data repository.
DESIGN, SETTING, AND PARTICIPANTS: In this cross-sectional study, patients with upcoming clinic appointments for glaucoma from March 16, 2020, to April 16, 2020, at an academic institution enrolled in the Sight Outcomes Research Collaborative (SOURCE) Ophthalmology Electronic Health Record Data Repository were identified. A risk stratification tool was developed that calculated a glaucoma severity and progression risk score and a COVID-19 morbidity risk score. These scores were summed to determine a total score for each patient.
Total scores and percentages of clinic appointments recommended for rescheduling.
Among the 1034 patients with upcoming clinic appointments for glaucoma, the mean (SD) age was 66.7 (14.6) years. There were 575 women (55.6%), 733 White individuals (71%), and 160 Black individuals (15.5%). The mean (SD) glaucoma severity and progression risk score was 4.0 (14.4) points, the mean (SD) COVID-19 morbidity risk score was 27.2 (16.1) points, and the mean (SD) total score was 31.2 (21.4) points. During pandemic-associated reductions in services, using total score thresholds of 0, 25, and 50 points would identify 970 appointments (93.8%), 668 appointments (64.6%), and 275 appointments (26.6%), respectively, for postponement and rescheduling. The algorithm-generated total scores also helped prioritize appointment rescheduling during the ramp-up phase.
A tool that considers the risk of underlying ophthalmic disease progression from delayed care receipt and the morbidity risk from COVID-19 exposure was developed and implemented, facilitating the triage of upcoming ophthalmic appointments. Comparable approaches for other ophthalmic and nonophthalmic care during the COVID-19 pandemic and similar crises may be created using this methodology.
在 2019 年冠状病毒病(COVID-19)大流行期间,护理威胁视力疾病(如青光眼)患者的眼科保健专业人员必须确定某些患者预约是否可以安全推迟,权衡患者青光眼在间隔期间恶化的风险与在寻求眼科护理时感染 COVID-19 的发病率风险。他们还需要在服务恢复阶段(当与大流行相关的服务减少得到缓解时)确定预约重新安排的优先级。
使用来自大型数据存储库的信息,描述一种用于青光眼患者的灵活且可扩展的评分算法,该算法考虑了青光眼的严重程度和进展风险,以及 COVID-19 发病率风险的高危特征。
设计、地点和参与者:在这项横断面研究中,确定了 2020 年 3 月 16 日至 2020 年 4 月 16 日期间在学术机构参加 Sight Outcomes Research Collaborative(SOURCE)眼科电子健康记录数据存储库的即将进行的青光眼诊所预约的患者。开发了一种风险分层工具,该工具计算了青光眼严重程度和进展风险评分以及 COVID-19 发病率风险评分。这些分数相加得出每个患者的总分。
推荐重新安排的诊所预约的总分和百分比。
在 1034 名即将进行青光眼诊所预约的患者中,平均(SD)年龄为 66.7(14.6)岁。其中 575 名女性(55.6%)、733 名白人(71%)和 160 名黑人(15.5%)。青光眼严重程度和进展风险评分的平均(SD)为 4.0(14.4)分,COVID-19 发病率风险评分的平均(SD)为 27.2(16.1)分,总评分的平均(SD)为 31.2(21.4)分。在与大流行相关的服务减少期间,使用总分阈值为 0、25 和 50 分将分别确定 970 次预约(93.8%)、668 次预约(64.6%)和 275 次预约(26.6%)的推迟和重新安排。算法生成的总分还有助于在服务恢复阶段确定预约重新安排的优先级。
开发并实施了一种考虑因延迟接受眼科治疗而导致潜在眼部疾病进展的风险以及 COVID-19 暴露的发病率风险的工具,从而促进了即将进行的眼科预约的分诊。在 COVID-19 大流行和类似危机期间,可能会使用这种方法为其他眼科和非眼科护理创建类似的方法。